A number of other analysts have also weighed in on CMBN. JPMorgan Chase & Co. reaffirmed a neutral rating and set a GBX 119 ($1.55) price objective on shares of Cambian Group PLC in a research report on Friday, July 15th. Canaccord Genuity reaffirmed a speculative buy rating and set a GBX 95 ($1.24) price objective on shares of Cambian Group PLC in a research report on Wednesday, September 14th. Five research analysts have rated the stock with a hold rating and one has assigned a buy rating to the company’s stock. The company currently has a consensus rating of Hold and a consensus target price of GBX 104.67 ($1.37).
Shares of Cambian Group PLC (LON:CMBN) traded up 10.09% during mid-day trading on Wednesday, reaching GBX 120.00. The company’s stock had a trading volume of 726,532 shares. The stock’s market capitalization is GBX 216.96 million. Cambian Group PLC has a 52 week low of GBX 48.25 and a 52 week high of GBX 290.00. The company’s 50-day moving average is GBX 87.43 and its 200-day moving average is GBX 68.76.
Cambian Group PLC Company Profile
Cambian Group plc is a provider of specialist behavioral health services for children and adults. The Company provides services to adults, which include specialist mental health services, acquired brain injury services and specialist residential care services. The services provided to children include specialist education services, specialist residential care services, foster care services and specialist mental health services.
Receive News & Ratings for Cambian Group PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cambian Group PLC and related companies with MarketBeat.com's FREE daily email newsletter.